This may be explained by a relatively low trial drug exposure (76%) compared to other CVOTs, and that the trial had no run-in period and, therefore, had one of the highest discontinuation rates
A combination of effects on CV risk factors and direct effect on the process of atherosclerosis are supported by preclinical studies where GLP-1RA showed anti-atherosclerotic and anti-inflammatory effects and improved endothelial function [73]
The research is still catching up, experts say, but that hasnt slowed interest in the approach one bit
Compounded drugs can be important for overcoming shortages or meeting unique patient needsbut compounders should not try to compound drugs in a way that circumvents FDAs approval process." The FDA claims the companies are mass marketing their GLP-1s as similar alternatives to FDA-approved drugs
The CNPV program may play an increasingly important role in speeding up access to therapies that address urgent health challenges
We conduct thorough medication reviews to identify potential drug interactions, especially for patients managing diabetes, hypertension, or hyperlipidemia, ensuring safe and effective treatment
)
